BR112018009386A8 - modificação de cristal termodinamicamente estável de 2-metil-n-(5-metil-1,3,4-oxadiazol-2-il)-3-(metilsulfonil)-4-(trifluorometil)benzamida - Google Patents

modificação de cristal termodinamicamente estável de 2-metil-n-(5-metil-1,3,4-oxadiazol-2-il)-3-(metilsulfonil)-4-(trifluorometil)benzamida

Info

Publication number
BR112018009386A8
BR112018009386A8 BR112018009386A BR112018009386A BR112018009386A8 BR 112018009386 A8 BR112018009386 A8 BR 112018009386A8 BR 112018009386 A BR112018009386 A BR 112018009386A BR 112018009386 A BR112018009386 A BR 112018009386A BR 112018009386 A8 BR112018009386 A8 BR 112018009386A8
Authority
BR
Brazil
Prior art keywords
methyl
oxadiazol
methylsulfonyl
benzamide
trifluoromethyl
Prior art date
Application number
BR112018009386A
Other languages
English (en)
Other versions
BR112018009386A2 (pt
Inventor
Köhn Arnim
Mehl Benedikt
Keil Birgit
Olenik Britta
Waldraff Christian
Hugh Rosinger Christopher
Original Assignee
Bayer Cropscience Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Cropscience Ag filed Critical Bayer Cropscience Ag
Publication of BR112018009386A2 publication Critical patent/BR112018009386A2/pt
Publication of BR112018009386A8 publication Critical patent/BR112018009386A8/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/101,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C07D271/1131,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/82Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with three ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)

Abstract

modificação de cristal termodinamicamente estável de 2-metil-n-(5-metil-1,3,4-oxadiazol-2-il)-3-(metilsulfonil)-4-(trifluorometil)benzamida. é descrita uma modificação de cristal termodinamicamente estável de 2-metil-n-(5-metil-1,3,4-oxadiazol-2-il)-3-(metilsulfonil)-4-(trifluorometil)benzamida. essa modificação de cristal termodinamicamente estável tem vantagens particulares na estabilidade de formulações da suspensão.
BR112018009386A 2015-11-09 2016-11-04 modificação de cristal termodinamicamente estável de 2-metil-n-(5-metil-1,3,4-oxadiazol-2-il)-3-(metilsulfonil)-4-(trifluorometil)benzamida BR112018009386A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15193615 2015-11-09
PCT/EP2016/076620 WO2017080912A1 (de) 2015-11-09 2016-11-04 Thermodynamisch stabile kristallmodifikation von 2-methyl-n-(5-methyl-1,3,4-oxadiazol-2-yl)-3-(methylsulfonyl)-4-(trifluoromethyl)benzamid

Publications (2)

Publication Number Publication Date
BR112018009386A2 BR112018009386A2 (pt) 2018-11-13
BR112018009386A8 true BR112018009386A8 (pt) 2019-02-26

Family

ID=54541996

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018009386A BR112018009386A8 (pt) 2015-11-09 2016-11-04 modificação de cristal termodinamicamente estável de 2-metil-n-(5-metil-1,3,4-oxadiazol-2-il)-3-(metilsulfonil)-4-(trifluorometil)benzamida

Country Status (12)

Country Link
US (1) US10336716B2 (pt)
EP (1) EP3374351A1 (pt)
JP (1) JP2018534294A (pt)
CN (1) CN108349916A (pt)
AU (1) AU2016352566A1 (pt)
BR (1) BR112018009386A8 (pt)
CA (1) CA3004360A1 (pt)
EA (1) EA201891102A1 (pt)
MX (1) MX2018005818A (pt)
UY (1) UY36982A (pt)
WO (1) WO2017080912A1 (pt)
ZA (1) ZA201802523B (pt)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10152459A1 (de) 2001-10-24 2003-05-08 Bayer Cropscience Ag Neue thermodynamisch stabile Kristallmodifikation von [2-(2-Chloro-4-mesyl-benzoyl)cyclohexane-1,3-dione]
HUE029871T2 (en) * 2011-03-22 2017-04-28 Bayer Ip Gmbh N- (1,3,4-oxadiazol-2-yl) -arylcarboxylic acids and their use as herbicides

Also Published As

Publication number Publication date
ZA201802523B (en) 2019-01-30
MX2018005818A (es) 2018-08-01
WO2017080912A1 (de) 2017-05-18
CN108349916A (zh) 2018-07-31
AU2016352566A1 (en) 2018-05-10
EA201891102A1 (ru) 2018-11-30
JP2018534294A (ja) 2018-11-22
US10336716B2 (en) 2019-07-02
EP3374351A1 (de) 2018-09-19
BR112018009386A2 (pt) 2018-11-13
UY36982A (es) 2017-06-30
US20180319754A1 (en) 2018-11-08
CA3004360A1 (en) 2017-05-18

Similar Documents

Publication Publication Date Title
EA201992300A1 (ru) КРИСТАЛЛИЧЕСКАЯ ФОРМА 6-(ЦИКЛОПРОПАНКАРБОКСАМИДО)-4-((2-МЕТОКСИ-3-(1-МЕТИЛ-1H-1,2,4-ТРИАЗОЛ-3-ИЛ)ФЕНИЛ)АМИНО)-N-(МЕТИЛ-d3)ПИРИДАЗИН-3-КАРБОКСАМИДА
TN2018000369A1 (fr) Aromatic sulfonamide derivatives.
CL2016002169A1 (es) Inhibidores de diacilglicerol aciltransferasa 2 para uso en el tratamiento de trastornos metabólicos y relacionados.
EA201790892A1 (ru) Кристаллические формы 5-хлор-n4-[2-(диметилфосфорил)фенил]-n2-{2-метокси-4-[4-(4-метилпиперазин-1-ил)пиперидин-1-ил]}пиримидин-2,4-диамина
BR112017004613A2 (pt) processo para a preparação de 3-(3-cloro-1h-pirazol-1-il)piridina
UY35535A (es) ?Derivados de fenil sulfonamidas?.
EA201691600A1 (ru) Дигидропиридиноновые ингибиторы mgat2 для применения в лечении метаболических нарушений
CY1122506T1 (el) Κρυσταλλικη μορφη της ενωσης (s)-3-{4-[5-(2-κυκλοπεντυλ-6- μεθοξυ- πυριδιν-4- υλ)-[1,2,4]οξαδιαζολ-3- υλ]-2- αιθυλ-6-μεθυλ- φαινοξυ}- προπανο-1,2- διολη
PH12018501181A1 (en) Phenyl derivatives as cannabinoid receptor 2 agonists
UY35536A (es) ?derivados de sulfonamida?.
BR112018000094A2 (pt) modificação de cristal termodinamicamente estável de 2-cloro-3-(metilsulfanil)-n-(1-metil-1h-tetrazol-5-il)-4-(trifluorometil)benzamida
CL2017000663A1 (es) Uso de compuestos heterocíclicos fluoroalquenil sulfano para repeler moluscos
BR112018009386A2 (pt) modificação de cristal termodinamicamente estável de 2-metil-n-(5-metil-1,3,4-oxadiazol-2-il)-3-(metilsulfonil)-4-(trifluorometil)benzamida
IL263299A (en) Crystalline form of (r)-4-(5-(cyclopropylethynyl)isoxazol-3-yl)-n-hydroxy-2-methyl-2-(methylsulfonyl)butanamide as an antibacterial agent
BR112018068015A2 (pt) composições herbicidas que compreendem 2-cloro-3-(metilsulfanil)-n-(1-metil-1h-tetrazol-5-il)-4-(trifluorometil)benzamida
EA201792685A1 (ru) Фармацевтическая композиция для лечения воспалительных изменений прямой кишки
LT3468957T (lt) (r)-4-(5-(ciklopropiletil)izoksazol-3-il)-n-hidroksi-2-metil-2-(metilsulfonil)butanamido kristalinė forma kaip antibakterinis agentas
EA201890806A1 (ru) Ингибитор рецептора p2x7
TWD188375S (zh) Eye cream stick
CN302532199S (zh) 单连组合式家具(m06)
CN302450239S (zh) 办公桌(DIP88-I-plus)
CN302450240S (zh) 办公桌(DIP89-I-plus)
CN302577441S (zh) 手表(5577-01)
CN302577440S (zh) 手表(5597-01)
CN302577439S (zh) 手表(5595-01)

Legal Events

Date Code Title Description
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements